Maze Therapeutics, Inc. ( MAZE) - Key Metrics
MAZE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | -$0.77 | -$0.69 | -$0.69 |
| 2025Q1 | ? | -$0.75 | -$0.67 | -$0.68 |
MAZE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -3.99 |
| 2025Q1 | ? | -3.68 |
MAZE
Price: $24.27
52 week price:
Earnings Per Share: -2.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.4 billion